Nano biosensor unlocks tumor derived immune signals for the early detection of ovarian cancer
Biosensors and Bioelectronics · 2025-06 · 278 · 117368
DOI: 10.1016/j.bios.2025.117368 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biosensors and Bioelectronics, 2025-06. Verfasst von Yuvaraj Sekar und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Biomedical Engineering, Science and Technology (I BEST), Partnership Between Toronto Metropolitan University and St. Michael's Hospital…. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Biosensing Techniques, Neutrophils, Early Detection of Cancer. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Sciences and Engineering Research Council of Canada.
Abstract (Originalsprache)
Ovarian cancer is a critical health issue for women nowadays. Its impact is significant because of its high mortality rate (324,603 worldwide), late-stage diagnosis and poor survival rate. Lack of screening tests, vague symptoms, misdiagnosis, and age factor makes it even more difficult to detect. Neutrophils, a subset of immune cells, undergo tumor-specific changes as ovarian cancer progresses inside ovarian tumour microenvironment. Therefore, monitoring the time-specific activity of neutrophils in circulation has the potential to aid in the diagnosis of ovarian cancer. Most ovarian tumor-specific antigens are unknown, making it difficult to identify neutrophils associated with ovarian tumor. We present ovarian tumor-associated circulating neutrophil cell profiling as a stand-alone cancer diagnostic method using a liquid biopsy. Using a SERS-functionalized nano probe, the metabolic profiles of neutrophils from ovarian tumor interaction are detected. We demonstrate that neutrophils associated with cancer stem cells have a distinct metabolic profile and are useful in the diagnosis of early ovarian cancer. Using 5 μL of peripheral blood and an artificial neural network, the characteristics of neutrophil profiles in patient blood could distinguish cancer cohort from non-cancer (healthy) with a 90 % sensitivity and 100 % specificity. Our results demonstrate the viability of using circulating neutrophils for non-invasive cancer diagnostics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute for Biomedical Engineering, Science and Technology (I BEST), Partnership Between Toronto Metropolitan University and St. Michael's Hospital, Toronto, Ontario, M5B 1W8, Canada; Ultrashort Laser Nanomanufacturin…
- Department of Stomatology, Faculty of Dental Medicine, Universite de Montreal, Montreal, QC, H3C 3J7, Canada.
- Institute for Biomedical Engineering, Science and Technology (I BEST), Partnership Between Toronto Metropolitan University and St. Michael's Hospital, Toronto, Ontario, M5B 1W8, Canada; Nano Characterization Laboratory,…
Förderung
- Natural Sciences and Engineering Research Council of Canada
Zitieren
APA
Sekar, Y., Ishwar, D., Tan, B., & Venkatakrishnan, K. (2025). Nano biosensor unlocks tumor derived immune signals for the early detection of ovarian cancer. Biosensors and Bioelectronics, 278, 117368. https://doi.org/10.1016/j.bios.2025.117368
Vancouver
Sekar Y, Ishwar D, Tan B, Venkatakrishnan K. Nano biosensor unlocks tumor derived immune signals for the early detection of ovarian cancer. Biosensors and Bioelectronics. 2025;278:117368. doi:10.1016/j.bios.2025.117368
BibTeX
@article{Sekar2025,
author = {Sekar, Yuvaraj and Ishwar, Deeptha and Tan, Bo and Venkatakrishnan, Krishnan},
title = {Nano biosensor unlocks tumor derived immune signals for the early detection of ovarian cancer},
journal = {Biosensors and Bioelectronics},
year = {2025},
volume = {278},
pages = {117368},
doi = {10.1016/j.bios.2025.117368}
}
EUVIMED